These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12703180)

  • 1. [Hemostatic coronary risk factors in a healthy population of Maracaibo, Venezuela].
    Diez-Ewald M; Campos G; Rivero F; Alvarez L; Torres E; Arocha-Piñango CL; Ryder E; Arteaga-Vizcaíno M; Vizcaíno G; Fernández N
    Invest Clin; 2003 Mar; 44(1):21-30. PubMed ID: 12703180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.
    Klemm T; Mehnert AK; Siegemund A; Wiesner TD; Gelbrich G; Blüher M; Paschke R
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):568-72. PubMed ID: 16320153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of stress electrocardiogram on platelet function, concentration of von Willebrand factor and fibrinogen in hypertensive patients and healthy subjects].
    Torres-Guerra E; Diez-Ewald M; Vizcaíno G; Arteaga-Vizcaíno M; Sulbarán T
    Invest Clin; 2000 Jun; 41(2):105-16. PubMed ID: 10961046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship of fibrinogen with cardiovascular risk factors in healthy men from Maracaibo, Venezuela].
    Campos G; Diez-Ewald M; Ryder E; Torres-Guerra E; Fernández V; Rivero F; Arocha-Piñango CL;
    Invest Clin; 2008 Sep; 49(3):341-51. PubMed ID: 18846775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study.
    Yarnell J; McCrum E; Rumley A; Patterson C; Salomaa V; Lowe G; Evans A
    Eur Heart J; 2005 Feb; 26(4):332-42; discussion 317-8. PubMed ID: 15618045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
    Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of excessive bleeding associated with marginally low von Willebrand factor and mild platelet dysfunction.
    Gudmundsdottir BR; Marder VJ; Onundarson PT
    J Thromb Haemost; 2007 Feb; 5(2):274-81. PubMed ID: 17137472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
    Lee KW; Blann AD; Lip GY
    Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study).
    Tofler GH; Massaro J; Levy D; Mittleman M; Sutherland P; Lipinska I; Muller JE; D'Agostino RB
    Am J Cardiol; 2005 Nov; 96(9):1280-3. PubMed ID: 16253598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relation of socioeconomic levels and life style to fibrinogen and von Willebrand factor in healthy Venezuelans and those with ischemic cardiopathy].
    Rodríguez-Larralde A; Mijares ME; Nagy E; Espinosa R; Ryder E; Diez-Ewald MP; Torres E; Coll-Sangrona E; Rodríguez-Roa E; Carvajal Z; Lundberg U; Campos G; Gill A; Arocha-Piñango CL;
    Invest Clin; 2005 Jun; 46(2):157-68. PubMed ID: 16001747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Content and functional activity of von Willebrand factor in apheresis plasma.
    Burnouf T; Caron C; Burkhardt T; Goudemand J
    Vox Sang; 2004 Jul; 87(1):27-33. PubMed ID: 15260819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The minimum concentration of fibrinogen needed for platelet aggregation using ADP.
    Cornell RF; Randolph TR
    Clin Lab Sci; 2002; 15(1):30-6. PubMed ID: 12778954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the relationship of plasma fibrinogen, platelet aggregation rate and peripheral arterial occlusive disease].
    Wang J; Li XY; He Y; Ni B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jan; 26(1):1-4. PubMed ID: 15921581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease.
    Woodward M; Rumley A; Welsh P; MacMahon S; Lowe G
    J Thromb Haemost; 2007 Sep; 5(9):1795-800. PubMed ID: 17723116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the antagonism of von Willebrand factor but not fibrinogen by platelet alphaIIbbeta3 antagonists with prolongation of bleeding time.
    Aoki T; Tomiyama Y; Honda S; Mihara K; Yamanaka T; Okubo M; Moriguchi A; Mutoh S
    J Thromb Haemost; 2005 Oct; 3(10):2307-14. PubMed ID: 16150045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.